American Shared Hospital Services
| 2.52 | +0.0700 | +2.86% | Vol 785 | 1Y Perf -10.91% |
| Sep 22nd, 2023 15:35 DELAYED |
| BID | 2.52 | ASK | 2.53 | ||
| Open | 2.45 | Previous Close | 2.45 | ||
| Pre-Market | - | After-Market | - | ||
| - - | - -% |
| Target Price | - | Analyst Rating | — — 0.00 | |
| Potential % | - | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★★★★ 57.18 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★★★ 52.44 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 13.38 | Earnings Rating | Buy | |
| Market Cap | 15.73M | Earnings Date | 9th Nov 2023 | |
| Alpha | -0.00 | Standard Deviation | 0.10 | |
| Beta | 0.68 |
Today's Price Range 2.452.52 | 52W Range 2.333.75 | 5 Year PE Ratio Range -1.8029.80 |
Summary:
Sell
| Technical Indicators: | Neutral |
| Moving Averages: | Strong Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | -5.26% | ||
| 1 Month | -7.69% | ||
| 3 Months | -0.40% | ||
| 6 Months | -10.64% | ||
| 1 Year | -10.91% | ||
| 3 Years | 47.37% | ||
| 5 Years | -14.58% | ||
| 10 Years | -8.72% |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -5.04 | |||
ROE last 12 Months | 6.89 | |||
ROA (5Y Avg) | -2.59 | |||
ROA last 12 Months | 3.22 | |||
ROC (5Y Avg) | 0.00 | |||
ROC last 12 Months | 4.91 | |||
Return on invested Capital Q | 1.24 | |||
Return on invested Capital Y | 0.88 | |||
Assets Turnover | 0.40 | |||
Receivables Turnover | 3.50 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 14.30 | ||||
| 0.85 | ||||
| 1.20 | ||||
| 2.10 | ||||
| 3.40 | ||||
| 1.37 | ||||
| 0.90 | ||||
| 3.45 | ||||
| 20.75M | ||||
| Forward PE | - | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 3.70 | ||||
| 3.90 | ||||
| 0.37 | ||||
| 0.68 | ||||
| 4.70 | ||||
| Leverage Ratio | 2.10 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 42.90 | ||||
| 17.00 | ||||
| 41.60 | ||||
| -2.00 | ||||
| 8.44 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 14.71M | ||||
| 2.39 | ||||
| -4.20 | ||||
| -2.04 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q01 2024 | - | 0.07 | - |
| Q01 2023 | - | 0.03 | - |
| Q03 2022 | - | 0.05 | - |
| Q02 2022 | - | 0.08 | - |
| Q01 2022 | - | 0.04 | - |
| Q03 2021 | - | 0.01 | - |
| Q02 2021 | - | 0.03 | - |
| Q01 2021 | - | 0.00 | - |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Next Report Date | 9th Nov 2023 |
| Estimated EPS Next Report | - |
| Estimates Count | - |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 785 |
| Shares Outstanding | 6.24K |
| Shares Float | 3.96M |
| Trades Count | 28 |
| Dollar Volume | 1.97K |
| Avg. Volume | 9.13K |
| Avg. Weekly Volume | 10.69K |
| Avg. Monthly Volume | 7.50K |
| Avg. Quarterly Volume | 9.19K |
American Shared Hospital Services (AMEX: AMS) stock closed at 2.52 per share at the end of the most recent trading day (a 2.86% change compared to the prior day closing price) with a volume of 785.0000 shares and market capitalization of 15.73M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 14 people. American Shared Hospital Services CEO is Raymond C. Stachowiak.
The one-year performance of American Shared Hospital Services stock is -10.91%, while year-to-date (YTD) performance is -13.99%. AMS stock has a five-year performance of -14.58%. Its 52-week range is between 2.33 and 3.75, which gives AMS stock a 52-week price range ratio of 13.38%
American Shared Hospital Services currently has a PE ratio of 14.30, a price-to-book (PB) ratio of 0.85, a price-to-sale (PS) ratio of 1.20, a price to cashflow ratio of 2.10, a PEG ratio of -, a ROA of 3.22%, a ROC of 4.91% and a ROE of 6.89%. The company’s profit margin is 8.44%, its EBITDA margin is 41.60%, and its revenue ttm is $14.71 Million , which makes it $2.39 revenue per share.
Of the last four earnings reports from American Shared Hospital Services, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. American Shared Hospital Services’s next earnings report date is 09th Nov 2023.
The consensus rating of Wall Street analysts for American Shared Hospital Services is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for American Shared Hospital Services stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
American Shared Hospital Services has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
American Shared Hospital Services has a Sell technical analysis rating based on Technical Indicators (ADX : 21.89, ATR14 : 0.12, CCI20 : -119.07, Chaikin Money Flow : 0.16, MACD : -0.04, Money Flow Index : 29.41, ROC : -3.45, RSI : 44.88, STOCH (14,3) : 52.05, STOCH RSI : 0.41, UO : 62.88, Williams %R : -47.95), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of American Shared Hospital Services in the last 12-months were:
American Shared Hospital Services
American Shared Hospital Services is engaged in providing gamma knife stereotactic radiosurgery equipment and radiation therapy and related equipment to various medical centers in the United States. The company operates through its business operations i.e. Gamma Knife Stereotactic Radiosurgery which is an alternative to conventional brain surgery and/or radiation therapy; Image Guided Radiation Therapy which captures cone beam imaging, fluoroscopic and x-ray images, creating exact size, location and coordinates of tumors; and Proton Beam Radiation Therapy which treats prostate, brain, spine, head and neck, lung, breast, gastrointestinal tract, and pediatric tumors.
CEO: Raymond C. Stachowiak
Telephone: +1 415 788-5300
Address: Two Embarcadero Center, San Francisco 94111-4107, CA, US
Number of employees: 14
